Modelling the injured spinal cord using 3-dimensional cell cultures; strategies for improving tissue engineered repair by East, E. et al.
Open Research Online
The Open University’s repository of research publications
and other research outputs
Modelling the injured spinal cord using 3-dimensional
cell cultures; strategies for improving tissue engineered
repair
Conference or Workshop Item
How to cite:
East, E.; Golding, J. P. and Phillips, J. B. (2008). Modelling the injured spinal cord using 3-dimensional cell
cultures; strategies for improving tissue engineered repair. In: European Cells and Materials, 16(Supple) p. 51.
For guidance on citations see FAQs.
c© 2008 AO Foundation
Version: Version of Record
Link(s) to article on publisher’s website:
http://www.ecmjournal.org/journal/supplements/vol016supp03/pdf/v016supp03a051.pdf
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
European Cells and Materials Vol. 16. Suppl. 3, 2008 (page 51)                                            ISSN 1473-2262  
Modelling the injured spinal cord using 3-dimensional cell cultures; strategies 
for improving tissue engineered repair 
E East, J P Golding & J B Phillips 
Department of Life Science, The Open University, Walton Hall, Milton Keynes, UK. 
 
INTRODUCTION: Traumatic injuries to the 
spinal cord are debilitating and often lead to 
paralysis and loss of sensation.  CNS injury results 
in the formation of a glial scar that is largely 
composed of reactive, hypertrophic astrocytes 
which upregulate various markers including glial 
fibrillary acidic protein (GFAP) and sulphated 
protoglycans.  The glial scar microenvironment is 
inhibitory for axon growth and regeneration A 
common finding of strategies aimed at bridging 
CNS lesions [1], in particular recent tissue 
engineered approaches using fibronectin [2], is that 
whilst axons readily enter and traverse the bridging 
graft they generally fail to exit the graft and re-
enter the parenchyma due to the inhibitory glial 
scar at the graft-CNS interface.  The aim of this 
work was to create a 3D cell culture model of CNS 
reactive gliosis, in which improved tissue-
engineered repair strategies can be developed. 
 
METHODS:  Primary rat astrocytes were seeded 
onto collagen coated coverslips (2D) or into 3D 
collagen gels and the expression of markers 
associated with glial scar formation were analysed 
by immunocytochemistry (GFAP, chondroitin 
sulphate proteoglycan (CSPG), vimentin, 
aquaporin 4 (AqP4) and S100β).  To stimulate 
reactive gliosis, 3D astrocyte cultures were treated 
with TGFβ1 (10ng/ml) every other day for 15 days 
[3].  Cultures without TGF β1 were used as 
controls.  Expression of glial scar markers was 
assessed and measured using Volocity image 
analysis software (Improvision).  Cell perimeter 
was measured as an indicator of astrocyte 
activation. Area of immunoreactivity was 
measured for CSPGs released from astrocytes. 
 
RESULTS:  Astrocytes in 3D cultures had 
significantly less immunoreactivity for GFAP, 
CSPG, vimentin, AqP4 and S100β, than astrocytes 
in 2D cultures indicating a lower level of activation 
in 3D (fig 1).  However immunoreactivity for β-
actin did not differ in 2D or 3D.  Following 
treatment with TGFβ1, astrocytes in 3D became 
hypertrophic and reactive, with changes in the 
expression of gliosis markers over time relative to 
control cultures (fig 2).   
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Comparison of astrocyte activation markers in 
2D and 3D cultures in type I collagen.  Bars represent 
mean ± SD, ***P<0.001 2D vs 3D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2.  Increased astrocyte activation following TGFβ1 
treatment of 3D cultures. 
 
DISCUSSION & CONCLUSIONS:  Astrocytes 
in 3D are less reactive than their 2D counterparts, 
thus resembling the physiological in vivo situation 
and providing a useful system in which activation 
can be investigated.  TGFβ1 treated astrocytes over 
15 days take on characteristics of the mature glial 
scar, including their morphology and protein 
expression profile.  This model will provide a 
useful test-bed for tissue engineered strategies to 
improve axonal growth through the glial scar 
environment. 
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